Ukraine pharmaceuticals market will surpass its previous peak in 2008

13 July 2011

Ukraine's pharmaceutical market will be one of the fastest growing markets in Business Monitor International’s Central and Eastern Europe (CEE) coverage area over the next five years. In 2011, the country's pharmaceutical market will surpass its previous peak in 2008 before the Ukraine economy experienced one of the worst downturns in the region during the economic crisis. The country's huge potential is clear: it is a European Union (EU) neighbor; it has a large population; and significant urban residency.

However, its political risk also remains outsized and, while the present government enjoys a degree of stability not seen since before the Orange Revolution, it is also seen as authoritarian, overly close to Russia and could spur destabilizing protests and fresh political infighting. In the health care sector, the potential introduction of a mandatory health insurance scheme could be transformative, says BMI.

Headline expenditure projections

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical